Prostate Ponderings
Prostate cancer is the second leading cause of cancer related deaths among men in the U.S. and many Western countries. African-American men have had higher incidence and at least double the mortality rates compared to [...]
ODAC to Review the Application for Satraplatin on July 24, 2007
Spectrum Pharmaceuticals announces that the FDA's Oncology Drug Advisory Committee (ODAC) will review their very promising investigational drug Satraplatin for the Treatment of Hormone Refractory Prostate Cancer. The hearing will be held on July 24, [...]
The Wall Street Journal – Black Wednesday at the FDA
In today’s Wall Street Journal there is a fantastic opinion piece written by Dr. Mark Thornton, Black Wednesday at the FDA. Dr. Thornton points out that not only did the FDA not approve Provenge last [...]
Mother’s Day
Today is Mother's Day. Today is a day we remember and honor our own mother and our spouses. These are the very same women who have been our loving caretakers, a job that gets little [...]
The Wall Street Journal’s Health Blog Explodes with Anger about the Provenge Decision
The Wall Street Journal's health blog has exploded with comments about the recent article about the FDA and Provenge. Their piece along with the comments are a must read. You can see the blog at: [...]
Patient Action Sign-On Letter
There is a sign on action letter to the FDA regarding it's CR letter on Provenge, at www.malecare.com Please take a look and if you agree, sign on. Also, please help get the word out [...]
